{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:03:14Z","timestamp":1761894194471,"version":"3.44.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1016\/j.ophtha.2005.06.031","type":"journal-article","created":{"date-parts":[[2005,10,13]],"date-time":"2005-10-13T09:45:49Z","timestamp":1129196749000},"page":"2123-2130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Feasibility and Efficacy of a Mass Switch from Latanoprost to Bimatoprost in Glaucoma Patients in a Prepaid Health Maintenance Organization"],"prefix":"10.1016","volume":"112","author":[{"given":"Simon K.","family":"Law","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian J.","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ervin","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Caprioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2005.06.031_bib1","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1345\/aph.1A178","article-title":"Prostaglandin analog treatment of glaucoma and ocular hypertension","volume":"36","author":"Alexander","year":"2002","journal-title":"Ann Pharmacother"},{"issue":"suppl","key":"10.1016\/j.ophtha.2005.06.031_bib2","doi-asserted-by":"crossref","first-page":"S337","DOI":"10.1016\/S0039-6257(01)00224-7","article-title":"The pharmacology of bimatoprost (Lumigan)","volume":"45","author":"Woodward","year":"2001","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2005.06.031_bib3","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0161-6420(96)30749-5","article-title":"Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma","volume":"103","author":"Camras","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2005.06.031_bib4","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/S0161-6420(95)30798-1","article-title":"Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol","volume":"102","author":"Alm","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2005.06.031_bib5","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2165\/00002512-200320080-00005","article-title":"Latanoprost","volume":"20","author":"Perry","year":"2003","journal-title":"Drugs Aging"},{"issue":"suppl","key":"10.1016\/j.ophtha.2005.06.031_bib6","doi-asserted-by":"crossref","first-page":"S361","DOI":"10.1016\/S0039-6257(01)00219-3","article-title":"Six-month comparison of bimatoprost once-daily and twice-daily with timolol twice-daily in patients with elevated intraocular pressure","volume":"45","author":"Sherwood","year":"2001","journal-title":"Surv Ophthalmo"},{"issue":"suppl","key":"10.1016\/j.ophtha.2005.06.031_bib7","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.survophthal.2003.12.019","article-title":"Two-year double-masked comparison of bimatoprost with timolol in patients with glaucoma or ocular hypertension","volume":"49","author":"Cohen","year":"2004","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2005.06.031_bib8","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2165\/00002512-200219030-00008","article-title":"Topical bimatoprost","volume":"19","author":"Easthope","year":"2002","journal-title":"Drugs Aging"},{"key":"10.1016\/j.ophtha.2005.06.031_bib9","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0002-9394(01)01177-1","article-title":"Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension","volume":"132","author":"Netland","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2005.06.031_bib10","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0161-6420(02)01010-2","article-title":"Comparison of travoprost 0.0015% and 0.004% with timolol 0.5% in patients with elevated intraocular pressure","volume":"109","author":"Fellman","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2005.06.031_bib11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1185\/03007999909113368","article-title":"A comparison of the intraocular pressure-lowering effect of 0.5% timolol maleate and the docosanoid derivative of a PGF2 alpha metabolite, 0.12% unoprostone, in subjects with chronic open-angle glaucoma or ocular hypertension","volume":"15","author":"Nordmann","year":"1999","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ophtha.2005.06.031_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0002-9394(01)01337-X","article-title":"A double-masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open-angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension. 6 month data","volume":"133","author":"Nordmann","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2005.06.031_bib13","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/BF02853173","article-title":"Efficacy of bimatoprost in glaucoma and ocular hypertension unresponsive to latanoprost","volume":"19","author":"Williams","year":"2002","journal-title":"Adv Ther"},{"key":"10.1016\/j.ophtha.2005.06.031_bib14","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1089\/108076803321908329","article-title":"Ocular hypotensive efficacy of bimatoprost when used as a replacement for latanoprost in the treatment of glaucoma and ocular hypertension","volume":"19","author":"Bournias","year":"2003","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.ophtha.2005.06.031_bib15","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0161-6420(02)01891-2","article-title":"Effect of bimatoprost on patients with primary open-angle glaucoma or ocular hypertension who are nonresponders to latanoprost","volume":"110","author":"Gandolfi","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2005.06.031_bib16","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0002-9394(03)00102-8","article-title":"Medical therapy cost considerations for glaucoma","volume":"136","author":"Fiscella","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2005.06.031_bib17","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/00061198-200208000-00013","article-title":"Cost analysis of glaucoma medications","volume":"11","author":"Vold","year":"2002","journal-title":"J Glaucoma"},{"issue":"suppl","key":"10.1016\/j.ophtha.2005.06.031_bib18","doi-asserted-by":"crossref","first-page":"S353","DOI":"10.1016\/S0039-6257(01)00212-0","article-title":"Efficacy and safety of bimatoprost in patients with elevated intraocular pressure","volume":"45","author":"DuBiner","year":"2001","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2005.06.031_bib19","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/BF02850299","article-title":"Three-month comparison of bimatoprost and latanoprost in patients with glaucoma and ocular hypertension","volume":"18","author":"Gandolfi","year":"2001","journal-title":"Adv Ther"},{"key":"10.1016\/j.ophtha.2005.06.031_bib20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0002-9394(02)01827-5","article-title":"A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma","volume":"135","author":"Noecker","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2005.06.031_bib21","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0002-9394(03)00098-9","article-title":"A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure","volume":"135","author":"Parrish","year":"2003","journal-title":"Am J Ophthalmol"},{"issue":"suppl","key":"10.1016\/j.ophtha.2005.06.031_bib22","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.survophthal.2003.12.017","article-title":"24-hour IOP control with once-daily bimatoprost, timolol gel-forming solution, or latanoprost","volume":"49","author":"Walters","year":"2004","journal-title":"Surv Ophthalmol"},{"issue":"suppl","key":"10.1016\/j.ophtha.2005.06.031_bib23","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.survophthal.2003.12.016","article-title":"A randomized, investigator-masked comparison of diurnal responder rates with bimatoprost and latanoprost in the lowering of intraocular pressure","volume":"49","author":"Choplin","year":"2004","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2005.06.031_bib24","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ophtha.2004.08.022","article-title":"Latanoprost 0.005% versus bimatoprost 0.03% in primary open-angle glaucoma patients","volume":"112","author":"Konstas","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2005.06.031_bib25","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0002-9394(02)01980-3","article-title":"Conjunctival hyperemia in healthy subjects after short-term dosing with latanoprost, bimatoprost, and travoprost","volume":"135","author":"Stewart","year":"2003","journal-title":"Am J Ophthalmol"},{"issue":"suppl","key":"10.1016\/j.ophtha.2005.06.031_bib26","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.survophthal.2003.12.018","article-title":"A cost-effectiveness comparison of bimatoprost versus latanoprost in patients with glaucoma or ocular hypertension","volume":"49","author":"Walt","year":"2004","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2005.06.031_bib27","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0039-6257(04)00149-3","article-title":"A cost-effectiveness comparison of bimatoprost versus latanoprost in patients with glaucoma or ocular hypertension","volume":"49","author":"Schwartz","year":"2004","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2005.06.031_bib28","series-title":"Essentials of Pharmacy Law","first-page":"29","author":"Pisano","year":"2003"},{"key":"10.1016\/j.ophtha.2005.06.031_bib29","series-title":"Pharmacy Practice and the Law","first-page":"351","author":"Abood","year":"1997"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642005009085?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642005009085?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:50:30Z","timestamp":1758981030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642005009085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S0161642005009085"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2005.06.031","relation":{},"ISSN":["0161-6420"],"issn-type":[{"type":"print","value":"0161-6420"}],"subject":[],"published":{"date-parts":[[2005,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Feasibility and Efficacy of a Mass Switch from Latanoprost to Bimatoprost in Glaucoma Patients in a Prepaid Health Maintenance Organization","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2005.06.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}